Connect with us

Life Sciences

VA Expands Access to Virtual Reality Pain Therapy for Veterans with AppliedVR Partnership

What You Should Know: – The U.S. Department of Veterans Affairs (VA) is taking a major step forward in pain management by expanding its contract with…

Published

on

This article was originally published by HIT Consultant

What You Should Know:

– The U.S. Department of Veterans Affairs (VA) is taking a major step forward in pain management by expanding its contract with AppliedVR, a provider of immersive therapeutics (ITx) using virtual reality (VR).

– This contract expansion will significantly increase access to RelieVRx®, the first and only FDA-authorized in-home VR treatment for chronic lower back pain (CLBP).

Continue Use of Virtual Reality for Treating Chronic Low Back Pain

Chronic pain affects over 50% of Veterans receiving care at VA facilities, making it a critical area of focus.

VA Immersive, a division of the VA, is spearheading this initiative, aiming to integrate cutting-edge technology like VR into their healthcare system. AppliedVR and VA share a common vision to transform pain care for Veterans through access to innovative treatments like RelieVRx. RelieVRx offers a non-pharmacological, noninvasive treatment option, potentially reducing reliance on medication and its side effects.

The expanded contract will provide more Veterans with access to RelieVRx in the comfort of their own homes. The eight-week program has been shown to decrease pain intensity and improve quality of life for CLBP patients, with durable effects lasting up to 24 months.

“VA Immersive has been a trailblazer that is consistently at the forefront of health care innovation, actively fostering exploration and integration of cutting-edge technologies to enhance health care delivery and services,” said Matthew Stoudt, Co-founder and CEO of AppliedVR. “VA Immersive’s mission to set national standards for leveraging VR will accelerate the adoption of immersive therapeutics across VA, enabling our wounded warriors to receive next-generation treatments like RelieVRx.”

This expanded partnership between AppliedVR and the VA has the potential to revolutionize pain management for Veterans and pave the way for wider adoption of VR-based treatments in healthcare. By offering effective, non-invasive options, VR therapy can significantly improve the lives of millions of individuals suffering from chronic pain.

therapeutics

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending